Multi-Cancer Panel
Multi-Cancer Panel 71 genes
The Multi-Cancer Panel evaluates genes associated primarily with adult-onset, non-syndromic hereditary cancer predisposition across a broad range of organ systems.
The panel includes genes associated with cancer risk involving, but not limited to:
- Breast: hereditary breast cancer and related conditions
- Gynecologic: ovarian and uterine/endometrial cancers
- Gastrointestinal: colorectal, gastric, and pancreatic cancers
- Endocrine: thyroid, parathyroid, pituitary, and adrenal glands
- Genitourinary: renal/urinary tract and prostate cancers
- Skin: melanoma and basal cell carcinoma
- Brain and nervous system: hereditary predisposition to certain brain and nervous system cancers
Because these cancers can have significant genetic heterogeneity, clinical symptoms and family history alone may not always be sufficient to identify the underlying genetic cause. Additionally, some genes included in the panel may be associated with other medical conditions that are not included among the disorders specifically evaluated by this test.
Genetic testing may provide valuable information by helping to:
- Confirm or clarify a clinical diagnosis
- Assess hereditary cancer risk
- Inform disease prognosis and potential progression
- Support earlier detection and appropriate screening
- Guide family planning and genetic counseling
- Identify potentially affected family members
- Support consideration for relevant clinical trials
Important Testing Information:
This panel is specifically designed to identify heritable germline genetic variants. It is not intended to detect somatic mutations in tumor tissue and should not be used as a substitute for tumor-based somatic testing.